Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
INDUSTRY
×
Pluvicto
×
Clear all
Filters
3
NCT04720157
2026-03-11
PSMAddition
Novartis
Phase 3
Active not recruiting
1,145 enrolled
NCT04689828
2026-02-20
PSMAfore
Novartis
Phase 3
Active not recruiting
469 enrolled
11 charts
1 FDA
NCT03511664
2025-01-13
VISION
Endocyte
Phase 3
Completed
861 enrolled
39 charts
1 FDA